Navigation Links
Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
Date:9/19/2013

e an important alternative to injectable therapies. The approvals of Lemtrada and Aubagio represent a significant step forward in the way we think about treating this disease," added Hans-Peter Hartung M.D., Ph.D., Professor and Chairman of the Department of Neurology at Heinrich-Heine-University in Duesseldorf, Germany. The Full Research Report on Sanofi SA - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-17/SNY]

--

AstraZeneca PLC Research Report

On September 13, 2013, AstraZeneca PLC (AstraZeneca) announced that the US Court of Appeals for the Federal Circuit (Federal Circuit) has issued a temporary injunction against the US launch of the 505(b)2 NDA Esomeprazole Strontium product of Hanmi Pharmaceutical (Hanmi). Previously, in June 2013, AstraZeneca had entered into an agreement with Hanmi and Amneal Pharmaceuticals (Amneal) to streamline litigation issues on the proposed Esomeprazole Strontium and, in July 2013, AstraZeneca had filed a Notice of Appeal for the Federal Circuit, with the Company seeking a reversal of claim construction. According to the release, Hanmi received US FDA approval for Esomeprazole Strontium on August 6, 2013. The Full Research Report on AstraZeneca PLC - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-17/AZN]

--

Neurocrine Biosciences, Inc. Research Report

On September 9, 2013, Neurocrine Biosciences, Inc. (Neurocrine) announced Phase IIb results for the 50mg dose of NBI-98854, a small molecule VMAT2 inhibitor in development for tardive dyskinesia. According to the results, the 5
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
8. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
9. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Finesse Solutions announced the expansion of its operations in ... planned for mid-March and access for customers is expected ... A-563, and located adjacent to the current office, the ... Finesse automation engineering team and allow Finesse to bring on ...
(Date:2/26/2015)... ITASCA, Ill. , Feb. 26, 2015  Today ... paper, The psychological and physical side effects ... belief that opioid painkillers, such as Vicodin and Oxycontin, ... "More Americans overdose on prescription painkillers than on ... , president and CEO of NSC. "Yet, these medications ...
(Date:2/26/2015)... Legislation passed today by the House Ways and Means ... prescriptions in Medicare Part D from crossing the pharmacy ... (PIMA) of 2014 , introduced by Ways and Means ... Ranking Member Jim McDermott (D-WA), recognizes the need to ... right policies, said the Pharmaceutical Care Management Association (PCMA). ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... DIEGO, Sept. 8, 2011 Marshall Edwards, Inc. (Nasdaq: ... the clinical development of novel therapeutics targeting cancer metabolism, ... trial of the Company,s lead drug candidate ME-143 in ... conducted in collaboration with the Sarah Cannon Research Institute ...
... Sept. 8, 2011 ChromaDex® Corp. (OTCBB: CDXC) ... has granted ChromaDex® the exclusive rights to a ... university for the method of inducing UDP-glucuronosyltransferase (UGT) ... a compound found in blueberries and demonstrated to ...
Cached Medicine Technology:Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 2Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 3ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers 2ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers 3
(Date:2/27/2015)... 2015 The Obrella Insider released ... Florida " report today. To determine the rankings, ... Census Bureau survey, considering only Florida cities whose ... survey. , The report visualizes compelling commuter data ... and a breakdown of commute durations. , View ...
(Date:2/27/2015)... On time and under budget, the ... Joplin. Inside and out, the nearly 900,000-square-foot facility makes ... replace the tornado-ravaged St. John’s Regional Medical Center with ... opening just 46 months after the tornado hit Joplin, ... anticipate to plan, design and construct a similarly sized ...
(Date:2/27/2015)... 27, 2015 The Radiology Business ... its next class of Fellows — one of the ... business management. , Since 2009, the RBMA Fellowship ... by RBMA members to the Association and the profession. ... because each Fellow candidate must meet a very high ...
(Date:2/27/2015)... February 27, 2015 Leading massage chair ... wellness to Americans nationwide. Each month they take a look ... and wellness, and healthy living. In the month of March ... Sleep Awareness Week starts by bringing awareness to the ... year Sleep Awareness Week will start on March 2nd, and ...
(Date:2/27/2015)... According to a Feb. 12, 2015 news ... to treat cancer by killing cancer stem cells, has received ... (FDA) for use in the treatment of mesothelioma.* According to ... to encourage the development of drugs for the treatment of ... FDA’s decision,” said Melinda Helbock, Founder of The Law Office ...
Breaking Medicine News(10 mins):Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3
... calcium intake by drinking milk or otherwise for middle aged ... disease is a disorder of the nervous system. Some of ... posture, slow voluntary movements, and a mask-like facial expression. ... of the 7,504 men in the ages of 45 yrs ...
... deficiency in people, lot of dietary ingredients these days contain ... by researchers of Medical University of South Carolina, US, had ... or more, intake of food fortified with iron might increase ... or iron overload is the opposite of iron deficiency and ...
... to Prevent Heart Attack Trial (ALLHAT) // results, most ... diuretics of the thiazide variety that are also sometimes ... of the study was published in this week’s The ... of the most important sets of trials conducted for ...
... steady rise in diseases caused due to allergens since the ... have analyzed the blood samples of 513 middle-aged men from ... samples of the same men from the past records of ... common test against allergens called Phadiatop. The samples that were ...
... Hospital, London, lupin flour have been identified as the ingredient ... also allergic to peanuts. ,Peanuts are known to cause ... are inflammation of the lips and the tongue, difficulty in ... need emergency hospitalization to make a full recovery. ...
... Southern California, US had been able to make a ... mother and maternal grandmother. ,The study had ... asthma regarding the smoking habits of the mother before, ... of other family members, especially that of the maternal ...
Cached Medicine News:
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
The design features of the Mini Lag Screw System simplify the screw fixation by reducing possible sources of error, reducing instrumentation, and decreasing the time of fixation....
... The Low Profile Leg Holder provides precise control ... leg rotation, and maximum exposure of the proximal ... Profile Leg Holder can be used on both ... to different heights.,The Low Profile Leg Holder can ...
Medicine Products: